Citichem India IPO vs Identical Brains Studios IPO

Comparison between Citichem India IPO and Identical Brains Studios IPO.

IPO Details

Citichem India IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Identical Brains Studios IPO is a SME Bookbuilding proposed to list at NSE SME.

Issue Size and Price

The total issue size of Citichem India IPO is up to ₹11.96 Cr whereas the issue size of the Identical Brains Studios IPO is up to ₹18.94 Cr. The final issue price of Citichem India IPO is ₹70.00 per share and of Identical Brains Studios IPO is ₹54.00 per share.

 Citichem India IPOIdentical Brains Studios IPO
Face Value₹10 per share₹10 per share
Issue Price (Lower)₹51.00 per share
Issue Price (Upper)₹54.00 per share
Issue Price (Final)₹70.00 per share₹54.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Discount (Employee)
Market Lot Size2000 shares2000 shares
Fresh Issue Size17,08,000 shares35,08,000 shares
Fresh Issue Size (Amount)up to ₹11.96 Crup to ₹18.94 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total17,08,000 shares35,08,000 shares
Issue Size Total (Amount)up to ₹11.96 Crup to ₹18.94 Cr

IPO Timetable

Citichem India IPO opens on Dec 27, 2024, while Identical Brains Studios IPO opens on Dec 18, 2024. The closing date of Citichem India IPO and Identical Brains Studios IPO is Dec 31, 2024, and Dec 20, 2024, respectively.

 Citichem India IPOIdentical Brains Studios IPO
Anchor Bid DateDec 17, 2024
Issue OpenDec 27, 2024Dec 18, 2024
Issue CloseDec 31, 2024Dec 20, 2024
Basis Of Allotment (Tentative)Jan 01, 2025Dec 23, 2024
Initiation of Refunds (Tentative)Jan 02, 2025Dec 24, 2024
Credit of Share (Tentative)Jan 02, 2025Dec 24, 2024
Listing date (Tentative)Jan 03, 2025Dec 26, 2024
Anchor Lockin End date 1Jan 22, 2025
Anchor Lockin End date 2Mar 23, 2025

Financials & KPIs

Citichem India IPO P/E ratio is 31.3, as compared to Identical Brains Studios IPO P/E ratio of 10.44.

 Citichem India IPOIdentical Brains Studios IPO
Financials

Company Financials (Restated)

Period Ended30 Jun 202431 Mar 202431 Mar 202331 Mar 2022
Assets68.5269.3379.7391.43
Total Income1.4919.6120.9485.28
Profit After Tax0.201.120.360.24
NET Worth7.457.256.135.77
Reserves and Surplus2.452.251.130.77
Total Borrowing1.081.081.101.11
Amount in ₹ Crore

Company Financials (Restated)

Period Ended30 Sep 202431 Mar 202431 Mar 202331 Mar 2022
Assets21.8417.024.762.26
Total Income11.5020.268.083.91
Profit After Tax2.415.351.610.51
NET Worth14.3612.042.891.27
Reserves and Surplus4.035.152.881.26
Total Borrowing0.170.19
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)83.2586.53
Promoter Shareholding (Post-Issue)61.2163.74
P/E Ratio31.310.44
Market Cap₹47.60 Cr.₹75.74 Cr.
ROE15.4271.66
ROCE21.47103.52
Debt/Equity0.150.02
EPS₹2.24₹5.17
RoNW15.4244.42

Shares Offered

In the Citichem India IPO Retail Individual Investors (RII) are offered 8,54,000 shares while in Identical Brains Studios IPO retail investors are offered 8,54,000 shares. Qualified Institutional Buyers (QIB) are offered in Citichem India IPO and 7,04,000 shares in Identical Brains Studios IPO.

 Citichem India IPOIdentical Brains Studios IPO
Anchor Investor Reservation10,48,000 shares
Market Maker Reservation92,000 shares1,86,000 shares
QIB7,04,000 shares
NII8,54,000 shares5,28,000 shares
RII8,54,000 shares12,28,000 shares
Employee
Others
Total17,08,000 shares35,08,000 shares

Bids Received (Subscription)

Citichem India IPO subscribed 410.53x in total, whereas Identical Brains Studios IPO subscribed 381.68x.

Compare with others

Compare: